TP53 and cervical adenocarcinoma: Evidence has shown missense mutations in TP53 in a considerable fraction of HPV-independent cervical adenocarcinomas, especially in aggressive subtypes such as gastric-type adenocarcinoma and mesonephric carcinoma [61].